CSSF flags 2025 upgrade of valuation practices in Luxembourg
In a move to strengthen valuation practices across the investment fund industry, Luxembourg’s financial supervisor CSSF on Wednesday unveiled a glimpse of plans to revise its valuation guidelines for investment fund managers. The update is due in 2025.
Transfer Thursday: M&G, BDO, HSBC, Governance.com
This week’s overview of transfers, appointments, promotions and other career news in the international fund and asset management community includes updates from M&G, BDO, Governance.com, the Luxembourg School of Business and the Luxembourg Competition Association.
Fine for Vistra over valuation errors heralds new regime in Luxembourg
Luxembourg’s financial regulator has issued a relatively small fine for a class of transgression with huge implications for the industry: valuations of funds, in particular for unlisted alternative investments.
NAV errors: Tighter control, clearer guidance seek to improve fund valuations
Luxembourg’s financial watchdog, the CSSF, has made important changes to its rules for valuations of investment funds, the first in two decades. While many things stay the same, some key updates—like lowering limits for money market funds and adding new checks before making investment decisions—are aimed at tightening control and providing clearer guidance.
China, a copy of the United States
Many investors mistakenly conclude that China and the United States are completely different due to their distinct financial (and societal) systems. However, nothing could be further from the truth. Both nations’ faltering economic engines are kept running by the same remedy: debt.
Morgan Stanley banker Albuquerque faces scrutiny as EU finance chief
Former Portuguese finance minister and Morgan Stanley banker Maria Luís Albuquerque, known for her austerity-heavy tenure during the eurozone crisis, is now the European Commission’s nominee for the influential role of Commissioner for Financial Services. Her appointment has already ignited controversy.
Fund Radar: Pharma companies regain their growth trajectory
Pharmaceutical companies were once known for their strong growth potential, but slowing revenue growth, lower valuations, and higher dividend yields have given them a more mixed profile in recent years. However, over the past three years, Novo Nordisk and Eli Lilly have stood out by reclaiming their growth status.
Transfer Thursday: Alfi, Marsh McLennan, EY, Amundi
This week’s overview of transfers, appointments, promotions and other career news in the fund and asset management community in and around Luxembourg includes updates from Alfi, Marsh McLennan, EY Luxembourg and Amundi.
Choosing Luxembourg over commuting
Gregory Kennedy reflects on cross-border commuting in Luxembourg, where once attractive border towns now face eroding quality of life.
JP Morgan, State Street dominate Luxembourg fund industry
JP Morgan and State Street have reinforced their dominance in Luxembourg’s fund industry, according to the latest Monterey Insights Luxembourg Fund Report 2024.